Viewing Study NCT00079950


Ignite Creation Date: 2025-12-24 @ 5:18 PM
Ignite Modification Date: 2025-12-24 @ 5:18 PM
Study NCT ID: NCT00079950
Status: SUSPENDED
Last Update Posted: 2012-09-06
First Post: 2004-03-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
Sponsor: Enzon Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module